Cardiovascular PET/MRI: Challenges and Opportunities

Cardiology Clinics

Volumn 34, Issue 1, 2016, Pages 25-35

  LaForest, Richard ^a   Woodard, Pamela K ^a   Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiovascular; Magnetic Resonace Imaging (MRI); Myocardium; PET MRI; Positron Emission Tomography (PET)

Indexed keywords

ACCURACY; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING SYSTEM; INTERMETHOD COMPARISON; MOLECULAR IMAGING; MYOCARDIAL DISEASE; MYOCARDIAL PERFUSION IMAGING; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY MAGNETIC RESONACE IMAGING; PRIORITY JOURNAL; REVIEW; MULTIMODAL IMAGING;

CARDIAC IMAGING TECHNIQUES; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84947474906     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2015.08.002     Document Type: Review

References (40)

1. Fink C., Krissak R., Henzler T., et al. Radiation dose at coronary ct angiography: second-generation dual-source ct versus single-source 64-mdct and first-generation dual-source ct. AJR Am J Roentgenol 2011, 196:W550-W557.
2. Koepfli P., Hany T.F., Wyss C.A., et al. Ct attenuation correction for myocardial perfusion quantification using a pet/ct hybrid scanner. J Nucl Med 2004, 45:537-542.
3. Weinreb J.C. Which study when? Is gadolinium-enhanced mr imaging safer than iodine-enhanced ct?. Radiology 2008, 249:3-8.
4. Zhang H., Shea S.M., Park V., et al. Accurate myocardial t1 measurements: toward quantification of myocardial blood flow with arterial spin labeling. Magn Reson Med 2005, 53:1135-1142.
5. Jin H., Zeng M.S., Ge M.Y., et al. 3d coronary mr angiography at 1.5 t: Volume-targeted versus whole-heart acquisition. J Magn Reson Imaging 2013, 38:594-602.
6. Sosnovik D.E., Wang R., Dai G., et al. Diffusion mr tractography of the heart. J Cardiovasc Magn Reson 2009, 11:47.
7. O'Connor R.D., Xu J., Ewald G.A., et al. Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: In vivo and ex vivo correlation in human subjects. Magn Reson Med 2011, 65:1234-1238.
8. Holloway C.J., Suttie J., Dass S., et al. Clinical cardiac magnetic resonance spectroscopy. Prog Cardiovasc Dis 2011, 54:320-327.
9. Ferreira V.M., Piechnik S.K., Robson M.D., et al. Myocardial tissue characterization by magnetic resonance imaging: novel applications of t1 and t2 mapping. J Thorac Imaging 2014, 29:147-154.
10. Sinusas A.J., Bengel F., Nahrendorf M., et al. Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging 2008, 1:244-256.
11. Rischpler C., Nekolla S.G., Dregely I., et al. Hybrid pet/mr imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med 2013, 54:402-415.
12. Catana C., Guimaraes A.R., Rosen B.R. Pet and mr imaging: the odd couple or a match made in heaven?. J Nucl Med 2013, 54:815-824.
13. Pichler B., Lorenz E., Mirzoyan R., et al. Readout of lutetium oxyorthosilicate crystals with avalanche photodiodes for high resolution positron emission tomography. Biomed Tech (Berl) 1997, 42(Suppl):37-38. [in German].
14. Coombs B.D., Szumowski J., Coshow W. Two-point dixon technique for water-fat signal decomposition with b0 inhomogeneity correction. Magn Reson Med 1997, 38:884-889.
15. Vontobel J., Liga R., Possner M., et al. Mr-based attenuation correction for cardiac fdg pet on a hybrid pet/mri scanner: comparison with standard ct attenuation correction. Eur J Nucl Med Mol Imaging 2015, 42:1574-1580.
16. Lau J.M., Laforest R., Sotoudeh H., et al. Evaluation of attenuation correction in cardiac pet using PET/MR. J Nucl Cardiol 2015, [Epub ahead of print].
17. Manber R., Thielemans K., Hutton B.F., et al. Practical pet respiratory motion correction in clinical pet/mr. J Nucl Med 2015, 56:890-896.
18. Furst S., Grimm R., Hong I., et al. Motion correction strategies for integrated pet/mr. J Nucl Med 2015, 56:261-269.
19. Pazhenkottil A.P., Nkoulou R.N., Ghadri J.R., et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J 2011, 32:1465-1471.
20. Gaemperli O., Saraste A., Knuuti J. Cardiac hybrid imaging. Eur Heart J Cardiovasc Imaging 2012, 13:51-60.
21. Mavrogeni S., Markousis-Mavrogenis G., Kolovou G. Contribution of cardiovascular magnetic resonance in the evaluation of coronary arteries. World J Cardiol 2014, 6:1060-1066.
22. Ishida M., Sakuma H. Coronary mr angiography revealed: how to optimize image quality. Magn Reson Imaging Clin N Am 2015, 23:117-125.
23. Chen D., Sharif B., Bi X., et al. Quantification of myocardial blood flow using non-electrocardiogram-triggered mri with three-slice coverage. Magn Reson Med 2015, [Epub ahead of print].
24. Butany J., Nair V., Naseemuddin A., et al. Cardiac tumours: diagnosis and management. Lancet Oncol 2005, 6:219-228.
25. Rahbar K., Seifarth H., Schafers M., et al. Differentiation of malignant and benign cardiac tumors using 18f-fdg pet/ct. J Nucl Med 2012, 53:856-863.
26. Nensa F., Tezgah E., Poeppel T.D., et al. Integrated 18f-fdg pet/mr imaging in the assessment of cardiac masses: a pilot study. J Nucl Med 2015, 56:255-260.
27. Calcagno C., Ramachandran S., Izquierdo-Garcia D., et al. The complementary roles of dynamic contrast-enhanced mri and 18f-fluorodeoxyglucose pet/ct for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging 2013, 40:1884-1893.
28. Ridker P.M., Luscher T.F. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 2014, 35:1782-1791.
29. Ripa R.S., Knudsen A., Hag A.M., et al. Feasibility of simultaneous pet/mr of the carotid artery: first clinical experience and comparison to pet/ct. Am J Nucl Med Mol Imaging 2013, 3:361-371.
30. Schatka I., Bengel F.M. Advanced imaging of cardiac sarcoidosis. J Nucl Med 2014, 55:99-106.
31. Osborne M., Kolli S., Padera R.F., et al. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol 2013, 20:310-312.
32. Maekawa Y., Anzai T., Yoshikawa T., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002, 39:241-246.
33. Dutta P., Nahrendorf M. Monocytes in myocardial infarction. Arterioscler Thromb Vasc Biol 2015, 35:1066-1070.
34. Wollenweber T., Bengel F.M. Molecular imaging to predict ventricular arrhythmia in heart failure. J Nucl Cardiol 2014, 21:1096-1109.
35. Chugh S.S., Reinier K., Teodorescu C., et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis 2008, 51:213-228.
36. Klem I., Weinsaft J.W., Bahnson T.D., et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012, 60:408-420.
37. Fallavollita J.A., Heavey B.M., Luisi A.J., et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014, 63:141-149.
38. Elhendy A., Chapman S., Porter T.R., et al. Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death. J Am Coll Cardiol 2005, 46:1721-1726.
39. Sinusas A.J., Lazewatsky J., Brunetti J., et al. Biodistribution and radiation dosimetry of lmi1195: first-in-human study of a novel 18f-labeled tracer for imaging myocardial innervation. J Nucl Med 2014, 55:1445-1451.
40. Dou K.F., Yang M.F., Yang Y.J., et al. Myocardial 18f-fdg uptake after exercise-induced myocardial ischemia in patients with coronary artery disease. J Nucl Med 2008, 49:1986-1991.